Viewing Study NCT06202261


Ignite Creation Date: 2025-12-24 @ 11:53 AM
Ignite Modification Date: 2025-12-29 @ 3:19 AM
Study NCT ID: NCT06202261
Status: RECRUITING
Last Update Posted: 2024-03-12
First Post: 2024-01-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-04-13
Start Date Type: ACTUAL
Primary Completion Date: 2026-12
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-10
Completion Date Type: ESTIMATED
First Submit Date: 2024-01-02
First Submit QC Date: None
Study First Post Date: 2024-01-11
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-03-10
Last Update Post Date: 2024-03-12
Last Update Post Date Type: ACTUAL